BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14969777)

  • 1. The deficit syndrome in schizophrenia: implications for the treatment of negative symptoms.
    Arango C; Buchanan RW; Kirkpatrick B; Carpenter WT
    Eur Psychiatry; 2004 Feb; 19(1):21-6. PubMed ID: 14969777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia.
    Horan WP; Blanchard JJ
    Schizophr Res; 2003 Dec; 65(2-3):125-37. PubMed ID: 14630305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The deficit syndrome: a domain of schizophrenia].
    Arango C; Kirkpatrick B; Buchanan RW; Carpenter WT
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(3):180-6. PubMed ID: 9717343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The psychiatric symptomatology of deficit schizophrenia: a meta-analysis.
    Cohen AS; Brown LA; Minor KS
    Schizophr Res; 2010 May; 118(1-3):122-7. PubMed ID: 19887305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using negative feedback to guide behavior: impairments on the first 4 cards of the Wisconsin Card Sorting Test predict negative symptoms of schizophrenia.
    Vogel SJ; Strauss GP; Allen DN
    Schizophr Res; 2013 Dec; 151(1-3):97-101. PubMed ID: 24210530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired facial affect labeling and discrimination in patients with deficit syndrome schizophrenia.
    Strauss GP; Jetha SS; Ross SA; Duke LA; Allen DN
    Schizophr Res; 2010 May; 118(1-3):146-53. PubMed ID: 20181462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status.
    Chemerinski E; Reichenberg A; Kirkpatrick B; Bowie CR; Harvey PD
    Schizophr Res; 2006 Jul; 85(1-3):12-9. PubMed ID: 16624531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported empathy deficits are uniquely associated with poor functioning in schizophrenia.
    Smith MJ; Horan WP; Karpouzian TM; Abram SV; Cobia DJ; Csernansky JG
    Schizophr Res; 2012 May; 137(1-3):196-202. PubMed ID: 22321668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight controlled for cognition in deficit and nondeficit schizophrenia.
    Dantas CR; Barros BR; Fernandes PT; Li LM; Banzato CE
    Schizophr Res; 2011 May; 128(1-3):124-6. PubMed ID: 21353484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to fill a half-full glass: emotion and schizophrenia.
    Aleman A; David AS
    Am Psychol; 2006 Jan; 61(1):75-6. PubMed ID: 16435982
    [No Abstract]   [Full Text] [Related]  

  • 11. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of neurocognitive impairment with diminished expression and apathy in schizophrenia.
    Hartmann-Riemer MN; Hager OM; Kirschner M; Bischof M; Kluge A; Seifritz E; Kaiser S
    Schizophr Res; 2015 Dec; 169(1-3):427-432. PubMed ID: 26526750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Persistent Negative Symptoms and Findings of Neurocognition and Neuroimaging in Schizophrenia.
    İnce E; Üçok A
    Clin EEG Neurosci; 2018 Jan; 49(1):27-35. PubMed ID: 29243526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive impairment in the deficit subtype of schizophrenia.
    Fervaha G; Agid O; Foussias G; Siddiqui I; Takeuchi H; Remington G
    Eur Arch Psychiatry Clin Neurosci; 2016 Aug; 266(5):397-407. PubMed ID: 26260899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome.
    Tandon R; DeQuardo JR; Taylor SF; McGrath M; Jibson M; Eiser A; Goldman M
    Schizophr Res; 2000 Oct; 45(3):191-201. PubMed ID: 11042437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive symptoms and social cognition impairment affect severity of suicidal ideation in schizophrenia.
    Comparelli A; Corigliano V; Lamis DA; De Carolis A; Stampatore L; De Pisa E; Girardi P; Pompili M
    Schizophr Res; 2018 Mar; 193():470-471. PubMed ID: 28712966
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissociation and social cognition in schizophrenia spectrum disorder.
    Renard SB; Pijnenborg M; Lysaker PH
    Schizophr Res; 2012 May; 137(1-3):219-23. PubMed ID: 22381192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment.
    Sharma T; Antonova L
    Psychiatr Clin North Am; 2003 Mar; 26(1):25-40. PubMed ID: 12683258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affect recognition in deficit syndrome schizophrenia.
    Bryson G; Bell M; Kaplan E; Greig T; Lysaker P
    Psychiatry Res; 1998 Feb; 77(2):113-20. PubMed ID: 9541147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.